Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
Processing Request
Effectiveness of a pathway-driven eHealth-based integrated care model (PEICM) for community-based hypertension management in China: study protocol for a randomized controlled trial.
Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
Processing Request
- معلومة اضافية
- المصدر:
Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE
- بيانات النشر:
Original Publication: [London] : BioMed Central, 2006-
- الموضوع:
- نبذة مختصرة :
Background: The prevalence of hypertension is high and increasing in China in recent years. The treatment and control of hypertension calls for long-term management beyond hospital, which is hard to implement in traditional care settings. Integrated care combined with information technology can promote high-quality healthcare services across the life-course. However, few studies have applied a customized integrated care model in community-based hypertension management in China, catering to the emerging "three-manager" mode. This study aims to identify the effectiveness of a pathway-driven eHealth-based integrated model that implemented as a full-featured telehealth system to facilitate standardized management of hypertension in China.
Methods: The trial has been designed as a 1-year, non-blinded superiority trial with two parallel groups. A total of 402 hypertensive patients who meet the eligibility criteria will be recruited and randomized with a 1:1 allocation. All the participants will receive a mobile device for self-management, which is a part of our telehealth system. Participants in the control group will only use the device for BP measurement and receive regular follow-ups from care providers according to the guidelines. Participants in the intervention group will gain full access to the system and receive intervention based on the proposed model (a well-designed coordinated care pathway consisting of 9 tasks). Outcomes will be measured mainly on three occasions (at inclusion, at 6 months, and at 12 months). The primary outcome is mean change in systolic blood pressure over a 12-month period. Secondary outcomes include changes in diastolic blood pressure, biochemical indexes related to hypertension, lifestyles, self-management adherence, and hypertension awareness, as well as work efficiency of care providers.
Discussion: This study aims to investigate whether a pathway-driven eHealth-based integrated care model based on the "three-manager" mode will improve hypertension control in China. Success of the model would help improve the quality of present community-based management procedures and benefit more patients with uncontrolled hypertension.
Trial Registration: Chinese Clinical Trial Registry ChiCTR1900027645 . Registered on November 22, 2019.
- References:
Nurs Stand. 2017 Jul 26;31(48):44-49. (PMID: 28745154)
Hypertens Res. 2013 Apr;36(4):313-21. (PMID: 23154592)
BMC Fam Pract. 2014 Dec 10;15:197. (PMID: 25491594)
Rech Soins Infirm. 2008 Jun;(93):94-105. (PMID: 18678084)
J Geriatr Cardiol. 2019 Mar;16(3):182-241. (PMID: 31080465)
JAMA. 2002 Oct 9;288(14):1775-9. (PMID: 12365965)
Trials. 2017 May 25;18(1):236. (PMID: 28545514)
J Med Internet Res. 2015 Apr 01;17(4):e86. (PMID: 25842005)
Lancet. 2010 Jul 17;376(9736):163-72. (PMID: 20619448)
Int J Environ Res Public Health. 2012 Mar;9(3):1018-29. (PMID: 22690180)
Hypertension. 2010 Jun;55(6):1346-51. (PMID: 20385970)
Clin Chim Acta. 2017 Feb;465:131-143. (PMID: 28007614)
JMIR Mhealth Uhealth. 2020 Feb 25;8(2):e14466. (PMID: 32130161)
Am Health Drug Benefits. 2010 Jan;3(1):47-56. (PMID: 25126308)
Health Aff (Millwood). 2009 Jan-Feb;28(1):75-85. (PMID: 19124857)
Medicine (Baltimore). 2015 Feb;94(5):e455. (PMID: 25654383)
Bull World Health Organ. 2014 Jan 1;92(1):29-41. (PMID: 24391298)
J Am Soc Hypertens. 2015 Feb;9(2):130-6. (PMID: 25660364)
Circulation. 2018 May 29;137(22):2344-2356. (PMID: 29449338)
Trials. 2018 Jul 16;19(1):385. (PMID: 30012188)
JAMA. 2002 Oct 16;288(15):1909-14. (PMID: 12377092)
BMJ. 2013 Apr 03;346:f1378. (PMID: 23558164)
Health Aff (Millwood). 2001 Nov-Dec;20(6):64-78. (PMID: 11816692)
Milbank Q. 1996;74(4):511-44. (PMID: 8941260)
Med Sci Sports Exerc. 2003 Aug;35(8):1381-95. (PMID: 12900694)
Sci Rep. 2016 Nov 14;6:37020. (PMID: 27841326)
Prog Cardiovasc Nurs. 2000 Summer;15(3):90-6. (PMID: 10951950)
BMJ. 2014 Mar 07;348:g1687. (PMID: 24609605)
J Am Acad Nurse Pract. 2012 Feb;24(2):89-96. (PMID: 22324864)
J Med Internet Res. 2015 Feb 24;17(2):e52. (PMID: 25803266)
Nutrients. 2014 Oct 28;6(11):4651-62. (PMID: 25353661)
BMC Fam Pract. 2018 Jan 9;19(1):11. (PMID: 29316889)
Ann Intern Med. 2013 Feb 5;158(3):200-7. (PMID: 23295957)
Hypertension. 2005 Jul;46(1):156-61. (PMID: 15939805)
- Grant Information:
2017YFC0114105 National Key Research and Development Program of China; 2018YFC0910503 National Key Research and Development Program of China; 2017YFB1002301 National Key Research and Development Program of China; 2018BFG02009 Key Research and Development Program of Ningxia Hui Autonomous of China
- Contributed Indexing:
Keywords: Community; Hypertension management; Integrated care; Pathway; Randomized controlled trial; Study protocol; Telehealth
- الموضوع:
Date Created: 20210123 Date Completed: 20210617 Latest Revision: 20210617
- الموضوع:
20221213
- الرقم المعرف:
PMC7820518
- الرقم المعرف:
10.1186/s13063-021-05020-2
- الرقم المعرف:
33482896
No Comments.